Related references
Note: Only part of the references are listed.Sulforaphane Ameliorates Neurobehavioral Deficits and Protects the Brain From Amyloid β Deposits and Peroxidation in Mice With Alzheimer-Like Lesions
Rui Zhang et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2015)
Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling
Manash K. Paul et al.
CELL STEM CELL (2014)
Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model
Hyunjin Vincent Kim et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2013)
Behavioral effects of Rho GTPase modulation in a model of Alzheimer's disease
Marco Musilli et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation
Huaping Chen et al.
EXPERIMENTAL CELL RESEARCH (2013)
Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke
Alessio Alfieri et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway
Shih-Hui Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Aβ increases neural stem cell activity in senescence-accelerated SAMP8 mice
Maria Diaz-Moreno et al.
NEUROBIOLOGY OF AGING (2013)
Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease
Fabiana Morroni et al.
NEUROTOXICOLOGY (2013)
Sulforaphane: translational research from laboratory bench to clinic
Christine A. Houghton et al.
NUTRITION REVIEWS (2013)
Attenuation of beta-Amyloid- Induced Oxidative Cell Death by Sulforaphane via Activation of NF-E2-Related Factor 2
Chan Lee et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Age-Dependent Neuroplasticity Mechanisms in Alzheimer Tg2576 Mice Following Modulation of Brain Amyloid-β Levels
Anna M. Lilja et al.
PLOS ONE (2013)
Coenzyme Q10 Restores Amyloid Beta-Inhibited Proliferation of Neural Stem Cells by Activating the PI3K Pathway
Hojin Choi et al.
STEM CELLS AND DEVELOPMENT (2013)
Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effect
Fulvia Zanichelli et al.
AGE (2012)
Structural influence of isothiocyanates on expression of cytochrome P450, phase II enzymes, and activation of Nrf2 in primary rat hepatocytes
M. La Marca et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Differential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model
Willem Kamphuis et al.
GLIA (2012)
Dementia From Alzheimer Disease and Mixed Pathologies in the Oldest Old
Bryan D. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Activation of the Nuclear Factor E2-Related Factor 2/Antioxidant Response Element Pathway Is Neuroprotective after Spinal Cord Injury
Xiaoliang Wang et al.
JOURNAL OF NEUROTRAUMA (2012)
Expression of APP, BACE1, AChE and ChAT in an AD model in rats and the effect of donepezil hydrochloride treatment
Qiang Li et al.
MOLECULAR MEDICINE REPORTS (2012)
ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression
Wolfram Hoetzenecker et al.
NATURE MEDICINE (2012)
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline
Johannes vom Berg et al.
NATURE MEDICINE (2012)
Genetics and epigenetics of Alzheimer's disease
Kannayiram Alagiakrishnan et al.
POSTGRADUATE MEDICAL JOURNAL (2012)
Sulforaphane protects primary cultures of cortical neurons against injury induced by oxygen-glucose deprivation/reoxygenation via antiapoptosis
Xuemei Wu et al.
NEUROSCIENCE BULLETIN (2012)
The Role of Phytochemicals in the Treatment and Prevention of Dementia
Melanie-Jayne R. Howes et al.
DRUGS & AGING (2011)
Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain
Fei Xiao et al.
NEUROSCIENCE BULLETIN (2011)
Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1ΔE9 mice
Yuan-Shih Hu et al.
FASEB JOURNAL (2010)
Modulation of Phase II Enzymes by Sulforaphane: Implications for Its Cardioprotective Potential
Cristina Angeloni et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion
Haigang Gu et al.
NEUROSCIENCE LETTERS (2009)
Sulforaphane improves cognitive function administered following traumatic brain injury
Prarnod K. Dash et al.
NEUROSCIENCE LETTERS (2009)
Current and future therapy in Alzheimer's disease
Robert J. van Marum
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Effects of systemic administration of β-casomorphin-5 on learning and memory in mice
M Sakaguchi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit
FJ Gil-Bea et al.
NEUROSCIENCE LETTERS (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Cholinergic function and Alzheimer's disease
E Giacobini
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
The magnitude of dementia occurrence in the world
A Wimo et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2003)
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo
C Scali et al.
NEUROSCIENCE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment
ST DeKosky et al.
ANNALS OF NEUROLOGY (2002)
Endomorphins 1 and 2, endogenous μ-opioid receptor agonists, impair passive avoidance learning in mice
M Ukai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)